Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,018,877 papers from all fields of science
Search
Sign In
Create Free Account
TRSUP-TTA1-1 gene
Known as:
TRSUP-TTA1-1
, transfer RNA suppressor (TTA) 1-1
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
CaV 3 . 2 T-type Ca 2 channels mediate the augmented calcium influx in carotid body glomus cells by chronic intermittent hypoxia
V. Makarenko
,
G. Ahmmed
,
+6 authors
N. Prabhakar
2015
Corpus ID: 16385398
Makarenko VV, Ahmmed GU, Peng YJ, Khan SA, Nanduri J, Kumar GK, Fox AP, Prabhakar NR. CaV3.2 T-type Ca channels mediate the…
Expand
2009
2009
Anatomical and Surgical Risk Factors Affecting the Internal Mechanical Conditions in the Transtibial Residuum
S. Portnoy
,
Z. Yizhar
,
+4 authors
A. Gefen
2009
Corpus ID: 108572805
Transtibial amputation (TTA) patients face ongoing morphological changes in their residual limb. The residuum volume changes due…
Expand
1996
1996
Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus
S. Devi
,
U. Hayat
,
J. Powell
,
J. Morris
Infection and Immunity
1996
Corpus ID: 20870234
Vibrio vulnificus is an oyster-associated bacterial pathogen that causes life-threatening fulminating septicemia and necrotizing…
Expand
1995
1995
Capsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus: construction, immunogenicity, and protective efficacy in a murine model
S. Devi
,
U. Hayat
,
C. Frasch
,
A. Kreger
,
J. Morris
Infection and Immunity
1995
Corpus ID: 2702074
Vibrio vulnificus causes septicemia and wound infections in immunocompromised humans. The capsular polysaccharide of Vibrio…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE